Lysosome triggered near-infrared fluorescence imaging of cellular trafficking processes in real time M Grossi, M Morgunova, S Cheung, D Scholz, E Conroy, M Terrile, ... Nature communications 7 (1), 10855, 2016 | 172 | 2016 |
Electron-multiplying CCD: the new ICCD DJ Denvir, E Conroy Low-Light-Level and Real-Time Imaging Systems, Components, and Applications …, 2003 | 120 | 2003 |
Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer B Li, T Ni Chonghaile, Y Fan, SF Madden, R Klinger, AE O'Connor, ... Cancer research 77 (14), 3834-3845, 2017 | 89 | 2017 |
Electron multiplying ccds DJ Denvir, E Conroy Opto-Ireland 2002: Optical Metrology, Imaging, and Machine Vision 4877, 55-68, 2003 | 54 | 2003 |
Colitis susceptibility in mice with reactive oxygen species deficiency is mediated by mucus barrier and immune defense defects G Aviello, AK Singh, S O'Neill, E Conroy, W Gallagher, G D'Agostino, ... Mucosal immunology 12 (6), 1316-1326, 2019 | 47 | 2019 |
A novel positron emission tomography (PET) approach to monitor cardiac metabolic pathway remodeling in response to sunitinib malate AC O’Farrell, R Evans, JMU Silvola, IS Miller, E Conroy, S Hector, M Cary, ... PloS one 12 (1), e0169964, 2017 | 40 | 2017 |
RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery D Wu, HC Daly, M Grossi, E Conroy, B Li, WM Gallagher, R Elmes, ... Chemical Science 10 (29), 6944-6956, 2019 | 37 | 2019 |
Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer AG Murphy, R Casey, A Maguire, M Tosetto, CT Butler, E Conroy, ... Scientific reports 6 (1), 34523, 2016 | 23 | 2016 |
BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer S Shields, E Conroy, T O’Grady, A McGoldrick, K Connor, MP Ward, ... Oncotarget 9 (21), 15673, 2018 | 20 | 2018 |
PEGylated BF2-Azadipyrromethene (NIR-AZA) fluorophores, for intraoperative imaging D Wu, HC Daly, E Conroy, B Li, WM Gallagher, RA Cahill, DF O'Shea European Journal of Medicinal Chemistry 161, 343-353, 2019 | 18 | 2019 |
Back-illuminated electron multiplying technology: the world’s most sensitive CCD for ultralow-light microscopy CG Coates, DJ Denvir, E Conroy, NG McHale, K Thornbury, M Hollywood Manipulation and Analysis of Biomolecules, Cells, and Tissues 4962, 319-328, 2003 | 16 | 2003 |
An EPR strategy for bio-responsive fluorescence guided surgery with simulation of the benefit for imaging HC Daly, E Conroy, M Todor, D Wu, WM Gallagher, DF O'Shea Theranostics 10 (7), 3064, 2020 | 12 | 2020 |
Implementing systems modelling and molecular imaging to predict the efficacy of BCL-2 inhibition in colorectal cancer patient-derived xenograft models AC O’Farrell, MA Jarzabek, AU Lindner, S Carberry, E Conroy, IS Miller, ... Cancers 12 (10), 2978, 2020 | 10 | 2020 |
1, 4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours CT Butler, SA Kennedy, A Buckley, R Doyle, E Conroy, WM Gallagher, ... Oncotarget 10 (38), 3725, 2019 | 7 | 2019 |
The molecular effects of a high fat diet on endometrial tumour biology M Wilkinson, P Sinclair, L Dellatorre-Teixeira, P Swan, E Brennan, ... Life 10 (9), 188, 2020 | 6 | 2020 |
Imaging intestinal ROS in homeostatic conditions using L-012 E Conroy, G Aviello NADPH Oxidases: Methods and Protocols, 313-327, 2019 | 5 | 2019 |
Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents IS Miller, LP Shiels, E Conroy, K Connor, P Dicker, WM Gallagher, ... Scientific Reports 9 (1), 9204, 2019 | 3 | 2019 |
Improvement of UV on/off ratios of a gated ICCD by simultaneously gating the MCP S Hamilton, E Conroy Opto-Ireland 2002: Optics and Photonics Technologies and Applications 4876 …, 2003 | 3 | 2003 |
Protocol for a preclinical systematic review and meta-analysis of pharmacological targeting of peroxisome proliferator-activated receptors in experimental renal injury WP Martin, YHD Chuah, E Conroy, AL Reynolds, C Judge, ... BMJ open science 5 (1), 2021 | 2 | 2021 |
Abstract PD3-01: CDK7: A marker of poor prognosis and tractable therapeutic target in triple-negative breast cancer WM Gallagher, B Li, T Ni Chonghaile, Y Fan, R Klinger, AE O'Connor, ... Cancer Research 76 (4_Supplement), PD3-01-PD3-01, 2016 | 2 | 2016 |